June 2020
Volume 61, Issue 7
Free
ARVO Annual Meeting Abstract  |   June 2020
Immuno-labeling of human anterior segments localizes trabecular meshwork-specific proteins identified by scRNA-seq
Author Affiliations & Notes
  • Maria Gomez-Caraballo
    Ophthalmology, Duke Eye Center, Durham, North Carolina, United States
  • Gaurang Patel
    Regeneron Pharmaceuticals, Inc., Tarrytown, New York, United States
  • Wen Fury
    Regeneron Pharmaceuticals, Inc., Tarrytown, New York, United States
  • Hua Yang
    Regeneron Pharmaceuticals, Inc., Tarrytown, New York, United States
  • Ming Yuan
    Regeneron Pharmaceuticals, Inc., Tarrytown, New York, United States
  • Ying Hu
    Regeneron Pharmaceuticals, Inc., Tarrytown, New York, United States
  • Carl Romano
    Regeneron Pharmaceuticals, Inc., Tarrytown, New York, United States
  • Daniel Stamer
    Ophthalmology, Duke Eye Center, Durham, North Carolina, United States
  • Footnotes
    Commercial Relationships   Maria Gomez-Caraballo, None; Gaurang Patel, Regeneron Inc (E); Wen Fury, Regeneron Inc (E); Hua Yang, Regeneron Pharmaceuticals, Inc. (E); Ming Yuan, Regeneron Pharmaceuticals, Inc. (E); Ying Hu, Regeneron Pharmaceuticals, Inc. (E); Carl Romano, Regeneron Pharmaceuticals, Inc. (E); Daniel Stamer, Regeneron Pharmaceuticals, Inc. (C), Regeneron Pharmaceuticals, Inc. (F)
  • Footnotes
    Support  5P30EY005722-34, Research to Prevent Blindness Unrestricted Grant, and Research to Prevent Blindness Medical Student Eye Research Fellowship
Investigative Ophthalmology & Visual Science June 2020, Vol.61, 4625. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Maria Gomez-Caraballo, Gaurang Patel, Wen Fury, Hua Yang, Ming Yuan, Ying Hu, Carl Romano, Daniel Stamer; Immuno-labeling of human anterior segments localizes trabecular meshwork-specific proteins identified by scRNA-seq. Invest. Ophthalmol. Vis. Sci. 2020;61(7):4625.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Dysfunction of the trabecular meshwork (TM) is responsible for ocular hypertension in primary open-angle glaucoma (POAG); however, TM-specific proteins are still unknown. We performed single-cell RNA sequencing (scRNA-seq) of TM and surrounding cells from human donor eyes. Candidate genes were mapped in human TM tissues via RNAscope®. The purpose of this study was validate RNA signatures and localize candidate gene products using immuno-labeling of iridocorneal angle sections.

Methods : Anterior segments from two human donor eyes were paraffin-embedded and sectioned for immuno-labeling of control proteins: CD31 (Schlemm’s canal, SC) and myocilin (TM), and candidate gene products: R-Spondin 2 (RSPO2), R-Spondin 4 (RSPO4), Chromogranin B (CHGB), Trefoil Factor 3, Transmembrane Protein 88, DNAX-Activation Protein 1, Proteolipid Protein 1, and Fms-Like Tyrosine Kinase 4. Sections underwent deparaffinization, antigen retrieval in citric acid buffer, and blocking in 5% normal serum at room temperature (RT) for 1 hour. Primary antibodies were incubated overnight at 4°C. Secondary antibodies were incubated with/without primary antibodies at RT for 1 hour. Experimental and control sections were imaged using a Nikon confocal microscope at identical settings. Z-stacks were merged and images were scored 0 (no labeling), 1+ (modest labeling) and 2+ (intense labeling).

Results : After optimization of antibodies, we visualized positive labeling from RSPO2, RSPO4, and CHGB proteins. RSPO2 and CHGB scored 2+ in the uveal, corneoscleral, and juxtacanalicular (JCT) TM, and was not present in SC cells. This distribution was consistent with the localization of these genes by RNAscope®. RSPO4 expression scored 2+ in the corneoscleral and 1+ in the JCT and uveal TM. Interestingly, we observed 1+ labeling of R-spondin-4 at SC; similar, albeit weaker, to that of the CD31 (2+). Perinuclear Myocilin staining was detected in the uveal, corneoscleral, and JCT TM with 2+ intensity. Other candidate proteins were undetectable using commercial antibodies

Conclusions : We have confirmed TM localization of the gene product candidates RSPO2, RSPO4, and CHGB, which are all secreted proteins. Interestingly, R-spondin proteins enhance wnt signaling, a known regulatory pathway of outflow resistance and intraocular pressure. These genes represent potential TM biomarkers in the study of the TM’s role in POAG pathology.

This is a 2020 ARVO Annual Meeting abstract.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×